...
首页> 外文期刊>Influenza and other respiratory viruses. >Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan
【24h】

Characterization of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan

机译:在日本大流行和大流行后的四个季节中分离到的对神经氨酸酶抑制剂具有抗药性的甲型H1N1)pdm09流感病毒的特征

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Objectives: Japan has the highest frequency of neuraminidase (NA) inhibitor use against influenza in the world. Therefore, Japan could be at high risk of the emergence and spread of NA inhibitor-resistant viruses. The aim of this study was to monitor the emergence of NA inhibitor-resistant viruses and the possibility of human-to-human transmission during four influenza seasons in Japan. Methods: To monitor antiviral-resistant A(H1N1)pdm09 viruses, we examined viruses isolated in four seasons from the 2008-2009 season through the 2011-2012 season in Japan by allelic discrimination, NA gene sequencing, and NA inhibitor susceptibility. Results: We found that 157 (1·3%) of 12 026 A(H1N1)pdm09 isolates possessed an H275Y substitution in the NA protein that confers about 400- and 140-fold decreased susceptibility to oseltamivir and peramivir, respectively, compared with 275H wild-type viruses. The detection rate of resistant viruses increased from 1·0% during the pandemic period to 2·0% during the post-pandemic period. The highest detection rate of the resistant viruses was found in patients who were 0-9 years old. Furthermore, among the cases with resistant viruses, the percentage of no known exposure to antiviral drugs increased from 16% during the pandemic period to 44% during the post-pandemic period, implying that suspected human-to-human transmission of the resistant viruses gradually increased in the post-pandemic period. Conclusions: A(H1N1)pdm09 viruses resistant to oseltamivir and peramivir were sporadically detected in Japan, but they did not spread throughout the community. No viruses resistant to zanamivir and laninamivir were detected.
机译:背景/目的:在世界上,日本使用神经氨酸酶(NA)抑制剂治疗流感的频率最高。因此,日本可能会出现耐NA抑制剂的病毒出现和传播的高风险。这项研究的目的是监测在日本的四个流感季节中耐NA抑制剂的病毒的出现以及人与人之间传播的可能性。方法:为了监测抗病毒抗性A(H1N1)pdm09病毒,我们通过等位基因识别,NA基因测序和NA抑制剂敏感性研究了从2008-2009年至2011-2012年在日本四个季节分离的病毒。结果:我们发现,在12 026 A(H1N1)pdm09菌株中,有157个(1·3%)在NA蛋白中具有H275Y取代,与275H相比,其对oseltamivir和peramivir的敏感性分别降低了约400倍和140倍。野生型病毒。抗药性病毒的检出率从大流行期间的1·0%增加到大流行后时期的2·0%。在0至9岁的患者中发现抗药性病毒的检出率最高。此外,在具有抗药性病毒的病例中,未知的抗病毒药物暴露百分比从大流行期间的16%增加到大流行后时期的44%,这表明怀疑的抗药性病毒逐渐在人与人之间传播在大流行后时期有所增加。结论:在日本偶发地发现了对奥司他韦和帕拉米韦具有抗药性的A(H1N1)pdm09病毒,但并未在整个社区中传播。未检测到对扎那米韦和拉尼米韦具有抗药性的病毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号